Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
AH
Amber Hill
R.grid, United Kingdom
Founder & CEO
HH
Hideki Hiraoka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
MH
Michal Hirsh-Vexberg
Israel Ministry of Health, Israel
Head of the Pharmaceuticals Registration Department, Medical...
Peter Hjelmstrom
Uppsala Monitoring Centre, Sweden
Director/CEO
Martin Hodosi
Kearney, United Kingdom
Partner, Healthcare and Life Sciences Practices
Eimy Honda
University of São Paulo - USP, Brazil
Cindy Hoots
AstraZeneca, United States
Chief Digital Officer and Chief Information Officer
Paula Horowitz
AbbVie, United States
Program Manager, QA, GCP Software Validation
Ryan Hoshi
AbbVie, United States
Director, Regulatory Policy and Intelligence
PH
Philip Hougaard
Lundbeck A/S, Denmark
Vice President, Biostatistics and Data Science
François Houyez
European Organisation for Rare Diseases (EURORDIS), France
Treatment Information and Access Director, Health Policy Advisor
Brett Howard
USP, United States
Senior Director, US Regulatory Policy
EH
Endang Hoyaranda
Indonesian Association For the Study of Medicinals (IASMED), Indonesia
President
Alice Hsu
Amgen Inc., United States
Director Integrated Signal Management
Angela Hu
PAREXEL International Inc., Taiwan
VP
Li Huang
Phastar, United States
Principal Biostatistician
Tse-Yin Huang
Center for Drug Evaluation, Taiwan, Taiwan
Reviewer
WH
Wei-I Huang
Taiwan Drug Relief Foundation, Taiwan
Director, Division of Drug Safety
Laura Huggins
Merck KGaA (EMD Serono), Germany
VP & Head, Global Regulatory Affairs Oncology & CDx
Melissa Hunt
Health Canada, Canada
Director
BH
Brian Hunter
CNS Healthcare, United States
Vice President of Contracts and Trial Management
Stacy Hurt, MBA, MHA
Parexel , United States
Chief Patient Officer
CH
Campbell Hutton
Breakthrough T1D, United States
Senior Vice President, Global Advocacy
Huong Huynh
Critical Path Institute, United States
Director of Regulatory Science
TH
Tran Huynh
Fortrea, United States
Director, Clinical Vendor Strategy
AH
Anna Hyde
Arthritis Foundation, United States
Vice President of Advocacy & Access
TAE HYUN
FDA, United States
Senior Statistical Reviewer, CDER
Edward Ian
Mediscience Planning Inc., Japan
Head of Integrated Innovation Service Center
Ana-Claudia Ianos
Pfizer Inc, United States
Senior Director, Safety Risk Management Lead
SI
Sameera Ibrahim
Bristol Myers Squibb, United Kingdom
Head of Risk Governance & Operations, R&D Quality
KI
Kentaro Ichinose
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Inspector
TI
Taruna Ikrar
Indonesia Food and Drug Authority, Indonesia
Chairperson
William Illis
Novartis , United States
Global Head, Collaboration/Technology Strategy, Clinical Development...
Anne Marie Inglis
GSK, United States
Senior Director, Clinical Operations Asset Lead
EI
Elizabeth Iorns
CEO and Co-Founder, United States
Science Exchange
MI
Maxwell Isaacoff
Elevance Health, Inc, United States
Director, Federal & External Affairs
AI
Akihiro Ishiguro
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Deputy Review Director, Office of New Drug III
Md Rashedul Islam
Queensborough Community College, United States
Undergraduate Research Scholar
DI
David Isom
Pfizer Inc, United States
Senior Director, Global Regulatory Policy and Intelligence, Global...
Aarthi Iyer
Cogent Biosciences, Inc., United States
Corporate Counsel
CJ
Charles Jaffee
HL7, United States
Chief Executive Officer
Nabeela Jahangeer
University of Southern California, United States
Student
Sheila Mahoney Jewels
LifeSciHub , United States
Drug Development Multi-Functionalist
TJ
Tony Johnson
Mallinckrodt Pharmaceuticals, United States
Senior Director, Clinical Quality
Jeremy Jokinen
Bristol-Myers Squibb Company, United States
Vice President and Head, Safety Evidence and Sciences
Brad Jordan
Eli Lilly and Company, United States
Associate Vice President, Regulatory Policy and Strategy
KW
Ken Wiley. Jr.
National Center For Advancing Translational Sciences, United States
Section Chief
TJ
Tom Julian
Gilead Sciences, United States
Assoc. Director Design and Innovation
ZJ
Zhanna Jumadilova
Pfizer Inc, United States
Clinical Lead
Patricia Jumelle
University of Southern California, United States
Student
HJ
HYUN JOO JUNG
Korea Institute of Drug Safety & Risk Management, Korea, Republic of
Departiment of Drug Safty Information
Andrea Jux
Genmab US, Inc., United States
Senior Director, Development Program Management
MIDHUN RAJ K
IQVIA, India
Manager, Signal Management
Rasika Kalamegham
Genentech, A Member of the Roche Group, United States
Head, US Regulatory Policy
Linda Kalilani
GlaxoSmithKline, United States
Senior Director and Head of Oncology Epidemiology
Joseph Kannarkat
Johns Hopkins University School of Medicine, United States
Physician
Chris Karlovich
Leidos Biomedical Research, United States
Director, Molecular Characterization Laboratory
SK
Stephen Karpen
Breakthrough T1D, United States
Senior Director, Regulatory Affairs
EK
Elaine Katrivanos
Tempus AI, United States
Senior Director Regulatory Affairs
Terry Katz
Daiichi Sankyo, United States
Senior Director, Biostatistics and DM Planning and Functional...
Melody Keel
The Research Associate Group, Inc., United States
Founder, CEO and Consultant
Lindsay Kehoe
Clinical Trials Transformation Initiative (CTTI), United States
Senior Project Manager, Lead Emerging Programs
Annie Kennedy
EveryLife Foundation for Rare Diseases, United States
Chief of Policy, Advocacy, and Patient Engagement
Jo Kerwin
Jo Ann Kerwin, United States
Senior Director Strategic Planning &. Operations
UK
Una Kessi
Oracle Health & Life Sciences, United Kingdom
Product Management Director, Safety and Pharmacovigilance
Madiha Khalid
Larimar Therapeutics, United States
Senior Director, Medical Writing
Irfan Khan
Circuit Clinical, United States
Founder and Chief Executive Officer
WK
Warren Kibbe
National Cancer Institute, United States
Deputy Director, Data Science and Strategy
BK
Bonggi Kim
Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Director
Jennifer Kim
Tufts Center for the Study of Drug Development, United States
Research Associate Professor
Yoon Jeon (Jamey) Kim
Merck & Co., Inc., Rahway, NJ, USA, Panama
Director, Cluster Pharmacovigilance Lead
Ray Kirchmier
Deloitte, United States
Manager
Yasuhiro Kishioka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer Director, Office of Cellular and Tissue-based Products
Teppei KIUCHI
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jesper Kjaer
Novo Nordisk, Denmark
Global Director for Public, Private Partnerships, Strat Ops, Global...
HK
Holly Kleinschrodt
Astellas, United States
Head, Device & Operations Quality
Timothy Kline
GSK, United States
Senior Director, Global Regulatory Affairs
NK
Nobutaka Kobayashi
Mitsubishi Tanabe Pharma Corporation, Japan
Deputy Director
Toshitatsu Kobayashi
Otsuka Pharmaceutical Co., Ltd., Japan
Senior Regulatory Expert
MK
Marina Kobiashvili
Independent Consultant, United States
AK
Armin Koch
Hannover Medical School, Germany
Head, Institute of Biometry
Ulrike Kochendoerfer
Pfizer Inc, United States
Senior Director, Medical Writing
CK
Chaitanya Koduri
US Pharmacopeia, United States
Director, International Government and Regulatory Engagement
Daisuke Koga
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of International Strategy and Planning
Isaac Kohane
Harvard Medical School, United States
Chair, Department of Biomedical Informatics
HK
Hema Kothari
Bristol Myers Squibb, United States
Scientific Writer II
MK
Maria Koukounari
BMS, United Kingdom
Senior Director Therapeutic Area Quality
Sandra Krogulski
Bristol Myers Squibb, United States
Director, GRSO Innovation and Business Operations Lead
AK
Andrea Kurz
F. Hoffmann-La Roche Ltd, Switzerland
Senior Director, Lead External Advocacy Europe & Middle East
Dominique Lagrave
Accumulus Synergy, United States
Senior Vice President of Regulatory Innovation
ML
Melissa Laitner
National Academy of Medicine, United States
Director, Strategic Initiatives
Mary Jo Lamberti
Tufts Center for the Study of Drug Development, United States
Director of Sponsored Research, Research Associate Professor
Celeste Frankenfeld Lamm
Merck Sharp & Dohme LLC , United States
Senior Director, Global Regulatory Affairs – CMC
Jeff Lange
Amgen, Hong Kong
Director of Observational Research in Asia
RL
Robyn Langham
Australia Health Products Regulation Group, Australia
Chief Medical Adviser
LL
Laura Lasiter
Astrazeneca, United States
Regulatory Affairs Director- Digital Health
Marion Laumonier
World Health Organization (WHO), Switzerland
Technical Officer, Regulatory Convergence and Networks
Agathe Le Lay
H. Lundbeck A/S, Denmark
Global Head of Value Evidence & Patient Insights
LL
Lauren Le
Butler University, United States
Student
Catherine Lee
Johnson and Johnson, United States
Associate Director - US Policy and Intelligence
IL
Iyn-Hyang Lee
College of Pharmacy, Yeungnam University, Korea, Republic of
Professor
Jeremiah Lee
University of Southern California, United States
Research Ambassador
KL
Kevin Lee
Clinvia, United States
Data Scientist
SL
Sue Lee
Takeda, United States
Director, Global Patient Safety Signal Management and Innovation
DL
Dianliang Lei
World Health Organization (WHO), Switzerland
Scientist of Technology, Standard and Norm
PL
Patty Leuchten
Diligent Pharma, United States
Founder and CEO
Bennett Levitan
Johnson & Johnson, United States
Executive Director, Benefit-Risk Assessment / Epidemiology
YL
Ye Li
FDA, United States
Mathematical Statistician, OTS, CDER
DL
Dun Liang
Eli Lilly & Co., United States
Director, Global Regulatory Affairs, Diagnostics
ML
Marie Liles-Burden
Takeda, United States
Director, Pharmacovigilance Risk Management
Min-Jung Lim
MediSafe, Pharmacovigilance Services, Korea, Republic of
CEO & Senior Pharmacovigilance Consultant
Anran Liu
U.S. Food and Drug Administration, United States
ORISE Postdoctoral Fellow
Hangyu (cedric) Liu
Biogen, United States
Associate Director, AI/ML
John Lockwood
Cencora Pharmalex, United States
Sr. Director
KV
Katherine Van Loon
UCSF Helen Diller Family Comprehensive Cancer Center, United States
Director, Global Cancer Program
Kevin Lu
Taimei Technology, United States
CTO
Jingyu (Julia) Luan
AstraZeneca, United States
Executive Regulatory Science Director, BioPharmaceuticals R&D
Tyler Ludlow
Decision Skills Institute, United States
Founder and Chief Decision Scientist
NM
Nell Meosky Luo
Folia Health, United States
Chief Executive Officer
Sarah Lyons
IQVIA, Canada
Head of Operations, Applied AI Science
Georgia Lytra
Syneos Health , United States
Engagement Manager, R&D Advisory
Tara MacCannell
Vertex Pharmaceuticals, United States
Global Head and Executive Director, RWE
Demetra Macheras
AbbVie, United States
Director, Regulatory Policy and Intelligence - Regulatory Affairs
Subha Madhavan
Pfizer Inc, United States
Vice President and Head of AI/ML, Global Biometrics and Data...
Nicole Mahoney
Novartis Pharmaceuticals Corporation, United States
Executive Director US Regulatory Policy & Intelligence
MM
Madhurima Majumder
Bayer US LLC, United States
Associate Director, Clinical Statistics and Analytics
TM
Tariro Makadzange
Zimbabwe Clinical Research Center, United States
Executive Director, Founder
RM
Ritika Malik
Temple University, United States
Student
Alison Maloney
Bayer , United States
Head of Regulatory Affairs North America
Shweta Maniar
Google Cloud, United States
Director, Healthcare and Life Sciences Solutions
Kwaku Marfo
IQVIA, Ghana
Africa Market Development Specialist
JM
Joseph Markmann
United States
Principal Data Science Lead, Global Regulatory Affairs
KM
Kristi Martin
Camber Collective, United States
Director
Sarah Martin
Eli Lilly & Co., United States
Senior Director - Global Regulatory Policy (Oncology)
Christine Mayer-Nicolai
Merck Healthcare KGaA, Germany
Vice President, Regulatory and Scientific Policy
Christy Mazzarisi
Network Partners Group, United States
Quality and Clinical COE Lead
Jennifer McCafferty
Merck, United States
Senior Vice President, Regulatory CMC and Quality Assurance
Neil McCullough
IQVIA, United States
Executive Vice President, Clinical Quality and Compliance
Allison McDougall
G3, United States
Executive Vice President
Niamh McGuinness
IQVIA, United States
Director of Pharma Solutions, Applied AI Science Team
Kelly McKee
Evinova, An Astrazeneca Company, United States
Head of Innovative Patient Recruitment
Mark McKenzie
EmVenio Research, United States
Chief Medical Officer
AM
Amanda McMannis
The Prostate Cancer Clinical Trials Consortium, United States
Associate Director, Clinical Operations
Lindsay McNair
Equipoise Consulting, United States
Principal Consultant
Melodi McNeil
AbbVie, United States
Director, Regulatory Affairs (Global Regulatory Lead, Oncology Early...
Carly McWilliams, MBA
Roche Diagnostics, United States
Head of Regulatory Policy
CM
Christine Mears
Generate BioMedicines, United States
Executive Director, Portfolio Management
David Meats
Certara, United States
Director, Regulatory Services & Medical Affairs Management
Ann Meeker-O'Connell
FDA, United States
Director, Office of Clinical Policy, Office of Clinical Policy and...
Doug Melton
Vertex, United States
Distinguished Research Fellow
Angela Men
The Whiteoak Group, Inc, United States
Chief Executive Officer
Amber Meriwether
Astellas Pharma, United States
Corporate Strategy
Danielle Metzger
PharmaQ Consulting, United States
Principal Quality Consultant
AM
Anton Mihic
McKinsey & Company, United States
Partner
Alexis Miller
Merck & Co., Inc., United States
Acting Global Lead, Global Regulatory Policy and Intelligence
BM
Bruce Miller
COPD Foundation, United States
Chief Scientific Officer
Yuki Miyatake
Eli Lilly Japan, Japan
Sr Manager
DM
David Moeny
FDA, United States
Acting Deputy Director, Office of Pharmacovigilance and Epidemiology,...
KM
Korrey Monroe
North Carolina Community Health Center Association, United States
Program Manager
Carol Morales
Astellas, United States
Lead, Quality Management and Capabilities
GM
Greg Morehouse
Abbvie, United States
Senior Manager, RA Device, Combination Products
MM
Marcelo Moreira
ANVISA, Brazil
GENERAL MANAGER
Toru Morishita
GlaxoSmithKline, United States
Manager, Global Regulatory Affairs
BM
Ben Moscovitch
Amazon Web Services, United States
Public Policy
TM
Taraneh Mousavi
University of Maryland, Baltimore, United States
PhD Student
FM
Florence Mowlem
Umotif, United Kingdom
Chief Scientific Officer
Katie Moy
Acadia Pharmaceuticals, United States
Associate Director, Medical Information & Review
Willie Muehlhausen
SAFIRA Clinical Research, Ireland
Co-Founder
David Mukanga
Bill & Melinda Gates Foundation, United States
Deputy Director, Africa Regulatory Systems
Saurabh Mukhopadhyay
Abbvie, United States
Research Fellow, Statistical Innovations
Theresa Mullin
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
Erin Mulrooney
Daiichi Sankyo, Inc, United States
Director, Portfolio Management
GM
Greeshma Mundayat
Maxisit, United States
Solution Owner
Ryan Murphy
ICON, United States
Associate Outcomes Researcher
KM
Kiran Musunuru
University of Pennsylvania, United States
Professor of Medicine
Nancy Myers
Catalyst Healthcare Consulting, United States
CEO and Founder
Jane Myles
Decentralized Trials and Research Alliance, United States
Program Director
Sridevi Nagarajan
Independent, United Kingdom
DIA Communities Lead for AI in Healthcare
Meera Nagaria
Johnson & Johnson, United States
Senior Data Scientist
Mehdi Najafzadeh
Medidata Solutions, United States
Senior Director
Kenichi Nakamura
National Cancer Center Hospital, Japan
Director, Department of International Clinical Development
SN
Sumati Nambiar
Johnson and Johnson, United States
Senior Director
Rohit Nambisan
Lokavant, United States
CEO & Co-Founder
SN
SRIVIDYA NARAYANAN
Northeastern University, United States
Student
Wassim Nashabeh
Genentech, A Member of the Roche Group, United States
Vice President, Global Head of Technical Regulatory Policy &...
Aliza Nathoo
F. Hoffmann-La Roche Ltd., Canada
Senior Director, Content Strategy
NN
Nancy Ngum
AUDA-NEPAD, South Africa
Public Health Officer
Christiane Niederlaender
Parexel International, United Kingdom
Vice President, Technical
Shinichi Noda
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Division Director, Division of Planning and Management, Office of...
Perla Nunes
Community Outreach and Clinical Research DEI Thought Leader, United States
Patient Advocate
JN
Jude Nwokike
USP, United States
Vice President and Director, PQM+
BO
Brendan O'Leary
United States
Consultant
SO
Sean Ogle
SEI Inc., United States
Senior Consultant
MO
Miyako Okayama
Otsuka Pharmaceutical, Co., Ltd., Japan
Regulatory Expert, Regulatory Technology & Operations Office,...
EO
Evon Okidi
Medidata Solutions, A Dassault Systemes Company, United States
Senior Data Scientist
Ebere Okpara
University of Illinois Chicago, United States
Research Assitant
Jimi Olaghere
United States
Patient Advocate
Adriane Alves de Oliveira
ANVISA, Brazil
Health Regulation Expert
RO
Rosemary Orciari
Pfizer, United States
Senior Directory, Reg Intel, Policy and QMS Lead
Feisal Othman
Bristol Myers Squibb, United States
Benefit Risk Assessment Lead
1
2
3
Share Modal
Share this link via
Or copy link
Copy